B. Metzler Seel. Sohn & Co. Holding Ag Dr Reddys Laboratories LTD Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 25,140 shares of RDY stock, worth $360,004. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,140
Previous 21,052
19.42%
Holding current value
$360,004
Previous $1.37 Million
145587.31%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
244Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$32.1 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$29.6 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28.6 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.9 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$25.8 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.38B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...